Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus

Aristotle University Of Thessaloniki

Status and phase: Completed; Phase 4

Conditions: Type II Diabetes Mellitus

Treatments: Drug: Rosiglitazone

Study type: Interventional

Funder types: Other

Identifiers

NCT00306176

1975

Details and patient eligibility

About

The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors

Sex: All

Ages: 40 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Type II diabetes mellitus
• Poor glycemic control

Exclusion criteria

• Heart failure
• Renal disease
• Liver disease
• Cardiovascular event

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)